RePORT International Resources

Influential Mentor Training - The TRAC Influential Mentors series comprises five virtual sessions that focus on recent scholarship on mentorship, tools for mentors and mentees to strengthen relationships, mentoring across cultures, and building mentoring programs. One session features a panel discussion where experienced mentors and mentees will share best practices and lessons learned. This series is tailored for TB research mentors and mentees from various backgrounds and ranks. Participants who attend four out of five sessions will receive a certificate, however registered participants can attend select sessions. The sessions are led by Dr. Dawn Comeau, Director of Mentor Training at Emory’s TRAC and Professor at Rollins School of Public Health.

The 4th Virtual Roadshow focused on public-private TB care service delivery models, hosted by the TBPPM Learning Network India Chapter, which brings together experts to discuss innovative TB-PPM models, private sector engagement strategies, and key insights from STOP TB projects.

ITM has a strong history and reputation in science, education and service delivery. Students from over 30 countries specialise in tropical infectious diseases and health care. Our scientists carry out research in laboratories and in the field, in collaboration with partners in Africa, Asia and Latin-America. Our doctors and nurses offer travel advice, vaccinations and medical care tailored to the individual patient, treating imported diseases, HIV and STDs.

This second session of the "New horizons for HIV vaccine R&D: An advocacy engagement series", titled: "Turning challenge into opportunity: Partnership models for sustained HIV vaccine research". This is the second webinar in the “New horizons for HIV vaccine R&D” advocacy engagement series. It builds on the first webinar, which examined African-led assets, gaps and opportunities amid global funding cuts (watch the recording on IAS+). Moving from mapping the moment to examining solutions, the discussion will: Place emphasis on African-led and Africa-centred partnerships Highlight strategies to reinforce local leadership, promote equitable collaboration Sustain long-term investment in HIV vaccine R&D Date: Tuesday, 3 March 2026 Time: 15:00-16:30 CET / 16:00-17:30 SAT / 17:00-18:30 EAT

Early Registration Deadline: 30 July 2026 Congress Dates: 10-13 November 2026 The Early Career Researcher Grants are available to support eligible applicants attending the 21st ICID Congress. These grants aim to reduce financial barriers and encourage participation from early-career professionals. This support opportunity is a part of the abstract submission process. You cannot apply for this Grant without submitting an abstract. The Grant Consists Of: Free registration: Complimentary access to Scientific sessions only. Workshops are not included. Hotel accommodation: 4 nights in a single room at a specified hotel, booked and paid for directly by the Congress organizers. Travel reimbursement: Economy class travel only. Reimbursement up to a predetermined amount based on the country of origin of the grant recipient, subject to receipt submission.

ISID mission is to empower clinical health experts and allied professionals to prevent, investigate, and manage infectious diseases within a One Health context. The ISID is committed to equity, prioritizing support for countries and regions with limited resources and disproportionately high infectious disease burdens. The conference will be in Madrid November 10-13, 2026

Abstract Submission Deadline: August 21st, 2026 We are pleased to announce that the 16th edition of the International Workshop on Clinical Pharmacology of Tuberculosis Drugs will take place October 14-15, 2026, as a virtual meeting. This abstract-driven workshop has been a leading annual meeting in the field of tuberculosis (TB) pharmacology since 2008. The aim of the meeting is to contribute to the optimization of TB treatment by providing an independent platform for the presentation and discussion of the latest scientific developments in TB pharmacology. If you work in TB, you are invited to join us. This includes preclinical and clinical pharmacology researchers from academia and industry; medical doctors, pharmacists, and pharmacologists involved in clinical management of TB patients; laboratorians, nurses, and PhD students; and representatives from regulatory or non-governmental organizations active in the TB field. The program consists of oral presentations that will be put in perspective, with a translation to clinical care where possible, by selected experts at the end of each workshop session. In addition, there will be e-poster abstract presentations. The workshop is informal in setting and is meant to be interactive.

Lecture by Dr. Tess Ryckman.

Podcast- Why TB, an ancient health threat, remains a public health threat.

The 2027 Keystone Conference on TB will be held Mar 1-4, 2027 at Mercure London Earls Court, London, United Kingdom. mportant Deadlines Early Registration Deadline: December 29, 2026 Scholarship Deadline: November 3, 2026 Global Health Award Deadline: September 29, 2026 Short Talk Abstract Deadline: November 3, 2026 Poster Abstract Deadline: February 8, 2027 Clinical detection and treatment of tuberculosis are still cumbersome, and new effective vaccines are not yet available. However, basic science is contributing significant new insights that can improve patient care and may ultimately control the pandemic. This symposium will foster interactions between basic and clinician scientists to focus research on the most prominent clinical needs and reciprocally to translate key findings into novel preventive, care and control strategies. Discussions will specifically focus on the heterogeneity of the host-pathogen interactions that underlie disease and represent a fundamental challenge to achieving this vision. By considering the full spectrum of disease, diversity of the host and pathogen, and environmental factors influencing immune control, we will refocus interventional strategies on those that will be most effective in the real world. Ultimately these insights should lead to the rational design and testing of vaccines that can prevent infection and disease in the global population, preventing not only acute disease but also post-TB sequelae.

Global Health Travel Awards (for the Global Health Series) are to enable attendance of scientists, physicians, fellows or students from countries where the meeting topic health problems are endemic. The purpose of providing travel awards is to add to the diversity of experiences represented by participants at each meeting. The award will cover conference-related expenses to include: meeting registration, lodging, airfare and ground transportation from host airport to the resort. The amount of the awards will vary, depending on where awardees are coming from and the extent of their need.

Grants Deadline AT MIDNIGHT CST Spring: February 1 - March 31 Fall: August 1 - September 30 The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation is seeking highly innovative and groundbreaking medical research proposals in both basic biological and applied research that will have the greatest impact on scientific knowledge and human health. The Foundation focuses on basic science and some translational - not clinical - research. All applications must be approved by the University Provost or the Vice President of Research, and should be submitted through the office of sponsored research or like office that provides institutional approval for the request. Studies selected through an internal competition are preferred. Applications submitted by an individual researcher will NOT be considered.

Presentation by Fuad Mirzayev from the WHO Global Programme on Tuberculosis and Lung Health during the Regional Workshop on accelerated implementation of WHO Guidelines on TB prevention, diagnosis, and drug-resistant TB (TB) treatment in Almaty, Kazakhstan. This event took place in collaboration with the World Health Organization (WHO) Global Programme on Tuberculosis and Lung Health, WHO European Region, together with Unitaid, Medecins Sans Frontires/Doctors Without Borders (MSF) and KNCV TB Plus on April 28 to 30, 2025.

This is a limited competition. The National Center for Advancing Translational Sciences (NCATS) will award Institutional Research Career Development (K12) programs through the Clinical and Translational Science Awards (CTSA). The purpose of this Notice of Funding Opportunity (NOFO) is to encourage institutions to propose creative and innovative institutional research career development programs designed to prepare an outstanding broadly-experienced pool of promising later stage postdoctoral fellows and junior faculty scholars who have made a commitment to independent clinical and translational science research careers (i.e., tenure-track or equivalent faculty positions) to facilitate their timely career advancement and continued engagement in research (i.e., sectors including academia, industry, nonprofit and government). Please refer to the website for detail announcement and key dates.

This is a limited competition. The National Center for Advancing Translational Sciences (NCATS) will award Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Institutional Research Training Grants for the Clinical and Translational Science Awards (CTSA) Program (T32) to eligible institutions to create, provide, and disseminate clinical and translational science training and career support programs that enhance postdoctoral research training of individuals with doctoral degrees (these include, but are not limited to, the following: D.M.D., DC, DO, DVM, OD, DPM, ScD, EngD, DrPH, DNSc, DPT, PharmD, ND [Doctor of Naturopathy], DSW, PsyD, as well as a doctoral degree in nursing research) and help ensure a pool of clinical and translational scientists trainees are equipped with the knowledge, skills and abilities to advance diagnostics, therapeutics, clinical interventions, and behavioral modifications that improve health and support meaningful translational science research projects that address demonstrable needs among stakeholder communities. Please refer to the website for detail announcement and key dates.

The Start4All Pooled Testing Toolkit is an open-access set of practical resources designed to support National TB Programs and implementing partners in planning, introducing, evaluating, and scaling up pooled sputum testing for tuberculosis (TB). The toolkit provides standard operating procedures, checklists, case studies, and instructional videos to guide consistent, safe, and effective implementation of pooled testing.

Presented by Hardy Kornfeld

Grant schedules and submission deadlines are fixed annually. (Spring and Fall cycles) The Mathers Foundation supports basic research with translational potential in areas such as immunology, microbiome, structural biology, cancer, genetics, stem cells, and neuroscience. We fund work that can lead to major advances in scientific understanding and human health. Please refer to the website for the details.

This resource is designed to support healthcare providers caring for young children who have been exposed to infectious TB. This guide emphasizes why rapid evaluation and action are critical for children under 5. It outlines key clinical steps and provides practical guidance on treatment, medication, and dosing.

The Mayo Clinic Center for Tuberculosis offers education, training, research support, and program development resources for healthcare professionals and public health providers. Please explore the website for more details.